Skip to main content
Premium Trial:

Request an Annual Quote

Sugen Uses Pangea's Tools To Reduce Redundancies


OAKLAND, Calif.--Sugen, a small molecule drug-discovery company wholly owned by Pharmacia and Upjohn, has licensed Pangea Systems' proprietary Clustering and Alignment Tools. Greg Plowman, Sugen's vice-president of molecular biology, said that the performance of Pangea's clustering tool on multiprocessor machines would allow Sugen to reduce the redundancies in its large sequence databases.

Filed under